Immune Pharmaceuticals Receives $2 Million Investment in Common Stock at $0.50 per Share

NEW YORK Sept. 7 2016 PRNewswire &160;Immune Pharmaceuticals Inc. NASDAQ IMNP "Immune" a biopharmaceutical company focused on the development of targeted therapeutics for the treatment of inflammatory diseases and cancer announced today that ...